PURE BIOSCIENCE, INC. (PURE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 07-31. Amounts in USD.

Revenue Quarterly

0 300K 600K 900K Q4 '24: 474K Q1 '25: 556K Q2 '25: 391K Q3 '25: 491K Q4 '25: 764K Q1 '26: 708K Q2 '26: 444K Q3 '26: 506K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Gross Profit Quarterly

0 200K 400K 600K Q4 '24: 275K Q1 '25: 325K Q2 '25: 227K Q3 '25: 283K Q4 '25: 468K Q1 '26: 450K Q2 '26: 238K Q3 '26: 269K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Operating Income Quarterly

-750K -500K -250K 0 250K 500K 750K Q4 '24: -699K Q1 '25: -627K Q2 '25: -725K Q3 '25: -584K Q4 '25: -336K Q1 '26: -379K Q2 '26: -683K Q3 '26: -518K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Net Income Quarterly

-900K -600K -300K 0 300K 600K 900K Q4 '24: -756K Q1 '25: -689K Q2 '25: -798K Q3 '25: -580K Q4 '25: -332K Q1 '26: -464K Q2 '26: -785K Q3 '26: -624K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Cost of Revenue Quarterly

0 150K 300K 450K Q4 '24: 199K Q1 '25: 231K Q2 '25: 164K Q3 '25: 208K Q4 '25: 296K Q1 '26: 258K Q2 '26: 206K Q3 '26: 237K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Operating Cash Flow Quarterly

-750K -500K -250K 0 250K 500K 750K Q4 '24: -593K Q1 '25: -503K Q2 '25: -544K Q3 '25: -512K Q4 '25: -456K Q1 '26: -250K Q2 '26: -606K Q3 '26: -468K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Free Cash Flow Quarterly

-1.1M -700K -350K 0 350K 700K 1.1M Q1 '22: -630K Q2 '22: -631K Q3 '22: -620K Q4 '22: -620K Q1 '23: -939K Q2 '23: -967K Q3 '23: -704K Q4 '23: -787K Q1 '22 Q2 '22 Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q2 '24: 111.9M Q3 '24: 111.9M Q1 '25: 111.9M Q2 '25: 111.9M Q3 '25: 111.9M Q1 '26: 111.9M Q2 '26: 111.9M Q3 '26: 110.8M Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.04 -0.03 -0.01 0.00 0.01 0.03 0.04 Q4 '24: -0.03 Q1 '25: -0.03 Q2 '25: -0.03 Q3 '25: -0.03 Q4 '25: -0.03 Q1 '26: -0.02 Q2 '26: -0.02 Q3 '26: -0.02 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.